Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

microRNA diagnostic panel for Alzheimer’s disease and epigenetic trade-off between neurodegeneration and cancer
Siranjeevi Nagaraj, Katarzyna Marta Zoltowska, Katarzyna Laskowska-Kaszub, et al.
Ageing Research Reviews (2018) Vol. 49, pp. 125-143
Open Access | Times Cited: 108

Showing 1-25 of 108 citing articles:

Blood-based molecular biomarkers for Alzheimer’s disease
Henrik Zetterberg, Samantha Burnham
Molecular Brain (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 230
Advances in the development of new biomarkers for Alzheimer’s disease
Timofey O. Klyucherev, Pawel K. Olszewski, Alena A. Shalimova, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 161
Epigenetics of Alzheimer’s Disease
Matea Nikolac Perković, Alja Videtič Paska, Marcela Konjevod, et al.
Biomolecules (2021) Vol. 11, Iss. 2, pp. 195-195
Open Access | Times Cited: 130
MicroRNAs in Alzheimer's disease: Potential diagnostic markers and therapeutic targets
Sen Liu, Min Fan, Qiang Zheng, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 148, pp. 112681-112681
Open Access | Times Cited: 129
MicroRNAs: pioneering regulators in Alzheimer’s disease pathogenesis, diagnosis, and therapy
Yao-Bo Li, Qiang Fu, Mei Guo, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Inhibition of miR-331-3p and miR-9-5p ameliorates Alzheimer's disease by enhancing autophagy
Menglu Chen, Chun‐Gu Hong, Tao Yue, et al.
Theranostics (2020) Vol. 11, Iss. 5, pp. 2395-2409
Open Access | Times Cited: 114
Increased miR‐34c mediates synaptic deficits by targeting synaptotagmin 1 through ROS‐JNK‐p53 pathway in Alzheimer’s Disease
Zhongli Shi, Kaixia Zhang, Huimin Zhou, et al.
Aging Cell (2020) Vol. 19, Iss. 3
Open Access | Times Cited: 99
miR-146a and miR-181a are involved in the progression of mild cognitive impairment to Alzheimer's disease
Abulaish Ansari, Elisabetta Maffioletti, Elena Milanesi, et al.
Neurobiology of Aging (2019) Vol. 82, pp. 102-109
Closed Access | Times Cited: 96
Profiling of Serum Exosome MiRNA Reveals the Potential of a MiRNA Panel as Diagnostic Biomarker for Alzheimer’s Disease
Zhiwu Dong, Hongjun Gu, Qiang Guo, et al.
Molecular Neurobiology (2021)
Closed Access | Times Cited: 81
Machine Learning to Detect Alzheimer’s Disease from Circulating Non-Coding RNAs
Nicole Ludwig, Tobias Fehlmann, Fabian Kern, et al.
Genomics Proteomics & Bioinformatics (2019) Vol. 17, Iss. 4, pp. 430-440
Open Access | Times Cited: 77
Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment
Nishit Pathak, Sunil Kumar Vimal, Ishi Tandon, et al.
Metabolic Brain Disease (2021) Vol. 37, Iss. 1, pp. 67-104
Closed Access | Times Cited: 70
Current Understanding of the Physiopathology, Diagnosis and Therapeutic Approach to Alzheimer’s Disease
Victoria García‐Morales, Anabel González‐Acedo, Lucia Melguizo‐Rodríguez, et al.
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1910-1910
Open Access | Times Cited: 60
miR-204 silencing reduces mitochondrial autophagy and ROS production in a murine AD model via the TRPML1-activated STAT3 pathway
Lu Zhang, Yu Fang, Xinyu Zhao, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 24, pp. 822-831
Open Access | Times Cited: 59
Exposure to a mixture of heavy metals induces cognitive impairment: Genes and microRNAs involved
Hai Duc Nguyen, Min‐Sun Kim
Toxicology (2022) Vol. 471, pp. 153164-153164
Closed Access | Times Cited: 56
Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases
Giulia Gentile, Giovanna Morello, Valentina La Cognata, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 5, pp. 770-770
Open Access | Times Cited: 48
Functional Nanomaterials for the Diagnosis of Alzheimer's Disease: Recent Progress and Future Perspectives
Saqer Al Abdullah, Lubna Najm, Liane Ladouceur, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 37
Open Access | Times Cited: 27
Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Alzheimer’s disease
Nourhan M. Abdelmaksoud, Al-Aliaa M. Sallam, Ahmed I. Abulsoud, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 155007-155007
Closed Access | Times Cited: 23
Serum Exosomal miRNA-125b and miRNA-451a are Potential Diagnostic Biomarker for Alzheimer’s Diseases
X N Duan, Qing Yin Zheng, Lihui Liang, et al.
Degenerative Neurological and Neuromuscular Disease (2024) Vol. Volume 14, pp. 21-31
Open Access | Times Cited: 12
Biomarkers in neurodegenerative diseases: a broad overview
Selvam Sathish, Velpandi Ayyavoo
Exploration of Neuroprotective Therapy (2024), pp. 119-147
Open Access | Times Cited: 10
Molecular Mechanisms Linking Osteoarthritis and Alzheimer’s Disease: Shared Pathways, Mechanisms and Breakthrough Prospects
Idiongo Okon Umoh, Helton José Reis, Antônio Carlos Pinheiro de Oliveira
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 3044-3044
Open Access | Times Cited: 9
Direct hybridization and bioinformatics analysis of circulating microRNAs in patients with Alzheimer’s disease under intravenous trehalose treatment
Shabnam Radbakhsh, Diana Marisol Abrego-Guandique, Tiziana Bacchetti, et al.
Brain Research (2025), pp. 149607-149607
Closed Access | Times Cited: 1
A Systematic Review of Suggested Molecular Strata, Biomarkers and Their Tissue Sources in ALS
Udaya Geetha Vijayakumar, Vanessa Milla, M. Stafford, et al.
Frontiers in Neurology (2019) Vol. 10
Open Access | Times Cited: 65
Molecular and Imaging Biomarkers in Alzheimer’s Disease: A Focus on Recent Insights
Chiara Villa, Marialuisa Lavitrano, Elena Salvatore, et al.
Journal of Personalized Medicine (2020) Vol. 10, Iss. 3, pp. 61-61
Open Access | Times Cited: 62
Gene biomarker discovery at different stages of Alzheimer using gene co-expression network approach
Negar Sadat Soleimani Zakeri, Saeid Pashazadeh, Habib MotieGhader
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 61
MicroRNA in Brain pathology: Neurodegeneration the Other Side of the Brain Cancer
Jakub Godlewski, Jacek Lenart, Elżbieta Salińska
Non-Coding RNA (2019) Vol. 5, Iss. 1, pp. 20-20
Open Access | Times Cited: 58
Page 1 - Next Page

Scroll to top